Skip to main content
logo
Becton, Dickinson and Company (BMV:BDX)
Mexico flag Mexico · Delayed Price · Currency is MXN
3,275.00
-44.20 (-1.33%)
At close: Jun 5, 2025

Revenue by Product

Fiscal year is October - September.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2012 - 2019
Medication Delivery Solutions
4.43B
Log In
Log In
Log In
Log In
Upgrade
Medication Delivery Solutions Growth
3.87%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Systems
2.27B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Systems Growth
0.44%
Log In
Log In
Log In
Log In
Upgrade
Biosciences
1.51B
Log In
Log In
Log In
Log In
Upgrade
Biosciences Growth
-3.41%
Log In
Log In
Log In
Log In
Upgrade
Other
-67.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medication Management Solutions
3.30B
Log In
Log In
Log In
Log In
Upgrade
Medication Management Solutions Growth
10.49%
Log In
Log In
Log In
Log In
Upgrade
Surgery
1.49B
Log In
Log In
Log In
Log In
Upgrade
Surgery Growth
1.33%
Log In
Log In
Log In
Log In
Upgrade
Peripheral Intervention
1.93B
Log In
Log In
Log In
Log In
Upgrade
Peripheral Intervention Growth
1.99%
Log In
Log In
Log In
Log In
Upgrade
Urology and Critical Care
1.55B
Log In
Log In
Log In
Log In
Upgrade
Urology and Critical Care Growth
4.09%
Log In
Log In
Log In
Log In
Upgrade
Medical
10.07B
Log In
Log In
Log In
Log In
Upgrade
Medical Growth
11.41%
Log In
Log In
Log In
Log In
Upgrade
Life Sciences
5.19B
Log In
Log In
Log In
Log In
Upgrade
Life Sciences Growth
-0.08%
Log In
Log In
Log In
Log In
Upgrade
Interventional
4.98B
Log In
Log In
Log In
Log In
Upgrade
Interventional Growth
2.45%
Log In
Log In
Log In
Log In
Upgrade
Other
-67.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is October - September.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2012 - 2019
Other
-2.88B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Medical Operating Income
2.74B
Log In
Log In
Log In
Log In
Upgrade
Medical Operating Income Growth
31.39%
Log In
Log In
Log In
Log In
Upgrade
Life Sciences Operating Income
1.60B
Log In
Log In
Log In
Log In
Upgrade
Life Sciences Operating Income Growth
1.55%
Log In
Log In
Log In
Log In
Upgrade
Other
-2.88B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Interventional Operating Income
1.42B
Log In
Log In
Log In
Log In
Upgrade
Interventional Operating Income Growth
17.19%
Log In
Log In
Log In
Log In
Upgrade